Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Operating Expenses | 68 | 2 | 4 | 3 | 7 |
| Operating Income | -68 | -2 | -4 | -3 | -7 |
| Pre-tax Income | -68 | -2 | -4 | -3 | -7 |
| Net Income Continuous | -68 | -2 | -4 | -3 | -7 |
| Net Income | $-68 | $-2 | $-4 | $-3 | $-7 |
| EPS Basic Continuous Ops | -0.15 | -0.03 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | -0.15 | -0.03 | 0.00 | 0.00 | -0.01 |
| EBITDA(a) | $-68 | $-2 | $-3 | $-3 | $-6 |